ELLEN LINTNER: Open Payments
NPI 1245740661 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,761 in 88 payments from 15 companies in 2025. Trend: 2023 $1,440 · 2024 $1,604 · 2025 $2,761
Food & beverage: $2,761
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 57 | $1,919 |
| Madrigal Pharmaceuticals | 4 | $171 |
| EVOKE PHARMA, INC. | 4 | $158 |
| Ipsen Biopharmaceuticals, Inc | 2 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $102 |
| PFIZER INC. | 3 | $56 |
| Ardelyx, Inc. | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 3 | $42 |
| VIVUS LLC | 2 | $34 |
| Braintree Laboratories, Inc. | 2 | $29 |
Products named: LINZESS, SKYRIZI, RINVOQ, CREON, REZDIFFRA, GIMOTI, MAVYRET, IQIRVO.
Industry payments across OH — which companies pay providers there.
